Analgesics in the United Kingdom - New Market Research Report

Analgesics is one of the largest and most significant product areas in OTC, accounting for 27% of overall value sales in 2015. However, this product area is largely mature. Furthermore, analgesics also faced considerable negative press coverage in 2015, including BBC's Panorama programme Hooked on Painkillers in November 2015 and the launch of Opoid Painkiller Addiction Awareness Day in September, alongside a host of newspaper articles. While the media is mainly focused on Rx analgesics, this negative publicity resulted in many consumers becoming less likely to take systemic analgesics in response to minor pain or ailments, particularly as the health and wellness trend is having an increasing impact on consumer habits. Adult ibuprofen saw 2% retail volume decline as a result of this trend, while adult aspirin also saw marginal decline and adult acetaminophen saw retail volume stagnation.

Full Report Details at
- http://www.fastmr.com/prod/1097820_analgesics_united_kingdom.aspx?afid=301

Competitive Landscape

Reckitt Benckiser (RB) is the clear leader in analgesics and accounted for close to 26% value share in 2015. The company benefits from the strength of its Nurofen brand, which alone accounted for 20% value share in the year and offers a wide range including adult and paediatric ibuprofen, combination products and topical analgesics/anaesthetic, alongside value-added formats such as Nurofen Meltlets. The company also offers numerous other distinctive brands such as Ralgex and Tiger Balm in topical analgesics/anaesthetic or Disprin in aspirin.

Industry Prospects

The health and wellness trend is expected to continue to impact sales of analgesics in the forecast period. Consumers will continue to shift their focus from treating symptoms to improving health, with many thus seeking to restrict their consumption of analgesics. This trend is expected to result in adult analgesics in particular suffering, with retail volume sales set to decline by over 4% in the forecast period. Aspirin is expected to suffer from a less healthy image in comparison to many other analgesics and will see 9% retail volume decline, while adult ibuprofen is expected to be hit by Nurofen being the first choice for many of those seeking to alleviate symptoms and will see similar decline.

Report Overview

Discover the latest market trends and uncover sources of future market growth for the Analgesics industry in United Kingdom with research from Euromonitor's team of in-country analysts.

Find hidden opportunities in the most current research data available, understand competitive threats with our detailed market analysis, and plan your corporate strategy with our expert qualitative analysis and growth projections.

If you're in the Analgesics industry in United Kingdom, our research will save you time and money while empowering you to make informed, profitable decisions.

The Analgesics in United Kingdom market research report includes:

About Fast Market Research

Fast Market Research is a leading distributor of market research and business information. Representing the world's top research publishers and analysts, we provide quick and easy access to the best competitive intelligence available. Our unbiased, expert staff is always available to help you find the right research to fit your requirements and your budget.

For more information about these or related research reports, please visit our website at http://www.fastmr.com or call us at 1.800.844.8156 (1.413.485.7001 Int'l)

You may also be interested in these related reports:

- Vitamin and Provitamin Market in United Kingdom to 2019 - Market Size, Development, and Forecasts
- Agricultural and Forestry Machine Market in United Kingdom to 2019 - Market Size, Development, and Forecasts
- Plastic Sheet, Plate and Film Market in United Kingdom to 2019 - Market Size, Development, and Forecasts
- Fertilizer Market in United Kingdom to 2019 - Market Size, Development, and Forecasts
- Sports Good Market in United Kingdom to 2019 - Market Size, Trends, and Forecasts